$AVXL News Article - Anavex Received Agreement from the Committee for Medicinal Products for Human Use (CHMP) for the Submission of a Marketing Authorisation Application of Oral Blarcamesine for Alzheimer's Disease
https://marketwirenews.com/news-releases/anav...89744.html